Tradestie Institutional Equity Comparison Engine
MESO vs CAPR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CAPR Overall Edge
CAPR Captures Institutional Edge (4โ0 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CAPR
MESO N/M vs CAPR 78.7x Fwd P/E
Growth & Margin Winner
CAPR
Op Margin -42.6% vs 0.0% ยท YoY +390.7% vs -7.9%
Momentum & Technical Winner
CAPR
1Y -16.4% vs +44.3% ยท 52W Pos 6% vs 15%
Options & Structure Winner
CAPR
UNCLASSIFIED (37th %ile IV) vs CONSOLIDATION (89th %ile IV)
MESO
NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap
$1.7B
1M Return
-6.1%
1Y Return
-16.42%
Forward P/E
N/M
Unified AI Score
34.6 / 100
SELL
Tech 25.0
Fund 40.0
Flow 50.0
Mom 50.0
CAPR
NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap
$595.4M
1M Return
+26.23%
1Y Return
+44.29%
Forward P/E
78.7x
Unified AI Score
28.0 / 100
SELL
Tech 50.0
Fund 37.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MESO -16.42%
CAPR +44.29%
Spread: +63.21 pp (CAPR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MESO TTM Op. Margin: -42.6%
CAPR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs CAPR. Trailing 12-month operating profitability (MESO -42.6% vs CAPR 0.0%) and valuation multiples (MESO N/M vs CAPR 78.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MESO | CAPR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7B | $595.4M | Larger Scale | MESO |
| Trailing P/E Ratio Valuation | N/M | 78.7x | Lower Multiple | CAPR |
| Forward P/E Ratio Valuation | N/M | 78.7x | Lower Multiple | CAPR |
| Revenue Growth (YoY) Growth | +390.7% | -7.9% | Higher Growth | MESO |
| Operating Margin (TTM) Profitability | -42.6% | 0.0% | Higher Margin | CAPR |
| Net Profit Margin Profitability | -47.8% | 0.0% | Higher Margin | CAPR |
| Return on Equity (ROE) Capital Efficiency | -9.9% | -100.5% | Higher ROE | MESO |
| 52-Week Range Position Momentum | 6% ($12โ$22) | 15% ($3โ$40) | Stronger Trend | CAPR |
| Beta / 30D Volatility Risk Regime | 1.18ฮฒ ยท 78% Vol | 1.52ฮฒ ยท 152% Vol | Lower Realized Risk | MESO |
| Unified Institutional Score Composite Signal | 34.6 / 100 (SELL) | 28.0 / 100 (SELL) | Higher Composite | MESO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MESO vs CAPR Buy Guide
MESO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
CAPR
CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
89th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MESO nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.